RE: Share price23 Sep 2021 13:58
Ryan .. I refer you to my earlier post. Insitutional investors can provide capital to expedite growth. Clearly with the balance sheet the way it is there is no sufficient cash or a desire to expand service facilities outside current ad hoc arranegments. So here we are the claimed 'fast growing' company strategy is dependent on ad hoc arrangements, short leases and little capex at exactly the same time that the CEO harps on about massive pharma spend on HCS and pharma services in the decade ahead. Cathal cannot achieve any such level of growth from any free cash flow in the future and so we are left with the waiting lists for clinic space and a ceiling to revenues in that space. So it is clear to me that either Cathal is running this on his original do up and sell strategy or may raise periodically and try to grow that way. There is no transparency and no large investors to support capex as II's do. There it is and that is my bear case on the CEO claims and how they don't seem achievable or realistic at this stage. No clear strategy just talk